Adolfo Ramirez-Zamora, MD, discusses the challenges when it comes to diversity when treating Parkinson’s Disease. He shares how to recognize the clinical symptoms of Parkinson’s Disease, characterizes the challenges that diverse populations experience when seeking care and discusses ideas on how to increase diversity in clinical practices. https://neurology.ufl.edu/wordpress/files/2022/04/uf_health_shands_ufhs057.mp3…
Christina Wilson, MD, compares and contrasts alteplase and tenecteplase for acute ischemic stroke. She characterizes the population of stroke patients that may benefit most from tenecteplase treatment and she helps us to recognize potential barriers to tenecteplase implementation. https://neurology.ufl.edu/wordpress/files/2022/04/uf_health_shands_ufhs062.mp3…
Michael Okun, MD, and Kelly Foote, MD, offer an update on DBS and Parkinson’s. They share the UF Research Study: Home-management of DBS settings and their recent clinical trial which is focused on patients being able to have their device systems at home, not in the clinic, which makes this…
Welcome to From Florida, a podcast where you’ll learn how minds are connecting, great ideas are colliding and groundbreaking innovations become a reality because of the University of Florida.
Join The Michael J. Fox Foundation and UF’s own, Dr. Ashley Rawls as part of an expert panel to discuss common Parkinson’s issues — “off” time and dyskinesia — and how to treat them. “Off” time is when symptoms return between medication. Dyskinesia is uncontrolled, involuntary movement. They cover…
SCCM Pod-410 COVID-19 Neurologic Manifestations Review neurologic manifestations of COVID-19 and other severe respiratory viral contagions (Robinson C, et al. Crit Care Explor. 2020;2:e0107) with host Ludwig H. Lin, MD, and author Christopher P. Robinson, DO, MS. In their discussion, they touch on Identifying primary and secondary neurological manifestations associated with COVID-19, the…
Tune in here to listen to Dr. Okun discuss Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease. …
Parkinson’s can be unpredictable – symptoms can come and go or get better and worse throughout the day. These so-called “on-off” fluctuations (also called motor fluctuations) and dyskinesias can be troubling, but movement disorder specialists can help with the choice of medication, dosages, and timing. Dr. Irene Malaty explains more…
Photo by Richard Clyborne of Music Strive Stem cells – those cells that can give rise to so many cell types in the body – have been touted as the cure-all for a variety of diseases, including Parkinson’s. But to date, attempts at stem cell transplantation into the brain…
The podcast covers a lot of ground, ranging from Parkinson’s diagnosis and symptoms to new studies to what the future holds for treatment of the disease. Nearly 60,000 Americans are diagnosed with Parkinson’s disease every year in the U.S. The disease is an incredibly complex disorder that affects more than…
